Allurion Technologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Allurion Technologies Inc in the first quarter 2026?
Due to the lack of equity, it was not possible to calculate Allurion Technologies Inc 's return on equity (ROE) in its first quarter 2026

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-33	-29	-24	-4	-3
Return On Equity (TTM)	-	-	-	-	-
ALUR's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-78	-77	-83	-64	-70
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	-	-	-	-	-

Back to ALUR Management Effectiveness >> ALUR's 5 Years Annual ROE >> Compare ALUR ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

ALUR Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023
Total Equity in Millions	-77	-78	-70	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-29	-26	-82	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

Back to ALUR Management Effectiveness >> ALUR's 5 Years Annual ROE >> Compare ALUR ROE to its Competitors

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ALUR's' Return on Equity at Yahoo Finance
ALUR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ALUR's Competitors
Subscribers only: Roe for Allurion Technologies Inc 's Suppliers
Subscribers only: Return On Equity for ALUR's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Medpace Holdings Inc	120.89 %
Capforce Inc	110.42 %
Eli Lilly And Company	101.17 %
Qhslab Inc	91.63 %
Amgen Inc	89.41 %
Exelixis Inc	88.60 %
Entera Bio Ltd	87.97 %
Tg Therapeutics Inc	87.36 %
Alnylam Pharmaceuticals Inc	86.11 %
Zevra Therapeutics Inc	81.34 %
Pulmatrix Inc	78.57 %
Earth Science Tech Inc	71.44 %
Idexx Laboratories Inc	70.87 %
Elite Pharmaceuticals Inc	68.60 %
Escalon Medical Corp	66.85 %
3m Company	65.54 %
Aurinia Pharmaceuticals Inc	64.48 %
Lifemd Inc	63.70 %
Zoetis Inc	61.63 %
Vaxart Inc	61.43 %
Dariohealth Corp	60.52 %
Nrc Health	57.25 %
Oramed Pharmaceuticals Inc	55.40 %
Innoviva Inc	47.59 %
Concentra Group Holdings Parent Inc	46.95 %
Liquidia Corporation	46.82 %
Agilent Technologies inc	44.45 %
Tenet Healthcare Corp	44.20 %
Theravance Biopharma inc	43.85 %
Gilead Sciences Inc	42.33 %

Date modified: 2026-08-30T15:05:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.